Recent Comments
- Joy Smith on The Declaration of Pandemics
- Linnea Comstock on The Declaration of Pandemics
- Lance W Richardson on The Declaration of Pandemics
- Sarah on The Declaration of Pandemics
- Bill on The Declaration of Pandemics
Most Viewed Posts
- Exclusive: Why the COVID “mRNA” vaccines are actually DNA gene therapies that must be removed from the market (22,829)
- Pfizer admits in federal court that the COVID gene therapies were never approved through the FDA (17,374)
- New treatment paradigm for C. Diff colitis (15,960)
- The Healthcare Channel hits 10 (15,251)
- Gordon Guyatt, MD: Update on the problem of clinical trials being stopped early to inflate efficacy of drugs (15,202)
- How the FDA regulates compounding pharmacies (15,007)
- I discuss the handling of the COVID-19 outbreak on The Joe Piscopo radio show (14,870)
- The Who’s Teen Cancer Lounge at Sloan Kettering opens (10,704)
- The new CDC guidelines for prescribing opioid pain pills (10,247)
- Exclusive: Michael Bloomberg took control of Johns Hopkins with his billions. Then, death rates skyrocketed at a children’s hospital. (10,103)
Pages
Categories
- – Biotech
- – Generics
- – JAMA
- – Medical Devices
- – NEJM
- – Opinion
- – Pharma
- – Policy
- – Reviews, books, devices
- – The Weekly Summary
- Bariatric surgery
- Cardiac surgery
- Cardiology
- Dermatology
- Diabetes and endocrinology
- Emergency medicine
- Gastroenterology and liver
- General surgery
- Genetics
- Geriatrics
- Infectious disease
- Internal Medicine
- Neurology
- Neurosurgery
- Obstetrics and Gynecology
- Oncology
- Ophthalmology
- Orthopedic surgery
- Pediatrics
- Plastic surgery
- Primary care medicine
- Psychology Psychiatry
- Pulmonology
- Radiology
- Rheumatology
- Spine surgery
- Sports medicine
- Transplant surgery
- Trauma Surgery
- Uncategorized
- Urology
- Vascular Surgery
- Z Medical centers
- Baylor
- Boston University
- Cedars Sinai
- Cleveland Clinic
- Columbia
- Cornell
- Duke
- Emory
- George Washington Univ
- Harvard
- Henry Ford
- Iowa State
- Johns Hopkins
- Mayo Clinic
- McMaster University
- Medical University of South Carolina
- Memorial Sloan-Kettering
- Michigan
- National Jewish Health
- NYU
- Ohio State
- Oregon Health and Science University
- UC Davis
- UC San Francisco
- UCLA
- Univ Kentucky
- Univ Maryland
- Univ Miami
- Univ Michigan
- Univ of Louisville
- Univ Texas
- VA Walter Reed
- Vanderbilt
- VCU
- Washington University
- Yale
Category Archives: Diabetes and endocrinology
Is Vitamin-D deficiency overdiagnosed?
November 8, 2016- Interviewed by Steven E. Greer, MD We interviewed JoAnn E. Manson, MD, DrPH, Chief, Division of Preventive Medicine, Brigham
Posted in - NEJM, - Policy, CDC, Diabetes and endocrinology, FDA, Harvard, Primary care medicine
Leave a comment
How did a small academic lab succeed where big medical device companies failed?
July 5, 2014- Interviewed by Steven E. Greer, MD The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas”
Hormone replacement therapy is safe and effective after all
November 14, 2017- Interviewed by Steven E. Greer, MD We interviewed JoAnn Manson, MD, DrPH about her JAMA paper that followed the cohorts in
The bionic pancreas data
July 2, 2014- Interviewed by Steven E. Greer, MD The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas”
Tandem Diabetes
August 27, 2015- Interviewed by Steven E. Greer, MD
Overview of rHGH therapy
January 14, 2015- Interviewed by Steven E. Greer, MD We interviewed Dr. Shlomo Melmed, Director of the Clinical Research Institute and Dean of Faculty at
Using Afrezza inhaled insulin with a CGM
November 3, 2014- Interviewed by Steven E. Greer, MD Inhaled insulin will make a comeback when Mannkind’s drug, Afrezza, goes on sale in early 2015.
Hacking CGM’s to smartphones
October 31, 2014– Interviewed by Steven E. Greer, MD Type 1 diabetes patients using continuous glucose monitors have been creating their own software,
Jay Skyler discusses the recent bionic pancreas data
June 22, 2014- By Steven E. Greer, MD This week, the mainstream press reported on the “bionic pancreas” data published in the NEJM
The serious adverse events caused by topical testoserone
March 1, 2014
Posted in - Pharma, Dermatology, Diabetes and endocrinology, FDA
Leave a comment
Alex Rodriguez’s PED schedule
January 12, 2014- By Steven E. Greer, MD CBS’s “60 Minutes” interviewed the man, Anthony Bosch, claiming to have been the pseudo-doctor
Posted in - Opinion, - Pharma, Congress, Diabetes and endocrinology
Leave a comment
The clinical hurdles to prescribing CGM
October 31, 2014– Interviewed by Steven E. Greer, MD The portion of total Type 1 diabetes patients who use continuous glucose monitors (CGM)
Interview with MannKind’s CEO, Al Mann, and CFO, Matt Pfeffer.
October 23, 2013- Interviewed by Steven E. Greer, MD The Healthcare Channel interviewed the CEO of MannKind, Al Mann, and the CFO, Matt Pfeffer.
Super rapid acting insulin and inhaled insulin
September 9, 2013- Interviewed by Steven E. Greer, MD Jay Skyler, MD, PhD, Deputy Director of the Diabetes Research Institute at The University
Posted in - Biotech, - Pharma, Diabetes and endocrinology, Univ Miami
Leave a comment